San Diego, CA, United States of America

Ajay Madan

This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Crinetics Pharmaceuticals, Inc.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ajay Madan. Retrieved from https://idiyas.com/inventor/ajay-madan-1wiwk56s

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ajay Madan: Innovator in Hepatic Impairment Treatment

Introduction

Ajay Madan is a notable inventor based in San Diego, CA. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of patients with hepatic impairment. His innovative work has led to the development of new methods and compositions that enhance patient care.

Latest Patents

Ajay Madan holds a patent for "Compositions and methods for administering paltusotine to patients with hepatic impairment." This patent outlines the compositions and methods for administering paltusotine, or a pharmaceutically acceptable salt thereof, to patients suffering from hepatic impairment. His work in this area is crucial for improving treatment options for affected individuals. He has 1 patent to his name.

Career Highlights

Ajay is currently employed at Crinetics Pharmaceuticals, Inc., where he continues to advance his research and development efforts. His role at the company allows him to collaborate with other experts in the field and contribute to innovative solutions in medicine.

Collaborations

Some of his notable coworkers include Sha Luo and Lance Goulet. Their combined expertise fosters a collaborative environment that enhances the development of new therapeutic approaches.

Conclusion

Ajay Madan's contributions to the field of pharmaceuticals, particularly in the treatment of hepatic impairment, highlight his dedication to improving patient outcomes. His innovative spirit and collaborative efforts continue to drive advancements in medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…